Search - tctmd.com

Displaying 601 - 620 of 847

Sort: Relevancy | Date

News Daily News

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Michael O'Riordan

April 24, 2018

News Daily News

Value of Ambulatory BP Monitoring Bolstered by Large Study

Todd Neale

April 18, 2018

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

News Daily News

Childhood Obesity Can Affect Cardiovascular Risk Even If Resolved by Adulthood

Yael L. Maxwell

April 11, 2018

News Daily News

Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI

Yael L. Maxwell

April 04, 2018

News Daily News

Unplanned Readmissions Within 30 Days Post-PCI Affect Nearly One in 10 US Patients

L.A. McKeown

April 04, 2018

News Daily News

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

Yael L. Maxwell

March 30, 2018

News Daily News

Videos Boost Oral and Written Explanations to Help Patients Understand PCI

L.A. McKeown

March 29, 2018

News Daily News

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

Caitlin E. Cox

March 26, 2018

News Conference News ACC 2018

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

Caitlin E. Cox

March 14, 2018

News Daily News

For CHD Patients, Physical Activity More Meaningful Than Weight Changes Over Time

Caitlin E. Cox

March 13, 2018

News Daily News

No Increased Risk of Serious Liver Injury Seen With NOACs

Todd Neale

March 13, 2018

News Conference News ACC 2018

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Michael O'Riordan

March 12, 2018

ACC 2018, Day Three: Gout, Hypertension, and Diabetes Dominate Opening Late Breaker

News Conference News ACC 2018

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

Shelley Wood

March 12, 2018

News Conference News ACC 2018

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Michael O'Riordan

March 10, 2018

News Conference News ACC 2018

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Shelley Wood

March 10, 2018

News Conference News ACC 2018

Googling of Cardiac Symptoms Tracks With Hospital Admissions for Coronary Disease

Yael L. Maxwell

March 09, 2018

News Conference News CRT 2018

Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT

Michael O'Riordan

March 08, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Daily News

Weighing of Female Sex in Stroke Risk Scores Needs Rethink in A-fib

Todd Neale

February 26, 2018

Advertisement

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Value of Ambulatory BP Monitoring Bolstered by Large Study

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Childhood Obesity Can Affect Cardiovascular Risk Even If Resolved by Adulthood

Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI

Unplanned Readmissions Within 30 Days Post-PCI Affect Nearly One in 10 US Patients

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

Videos Boost Oral and Written Explanations to Help Patients Understand PCI

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

For CHD Patients, Physical Activity More Meaningful Than Weight Changes Over Time

No Increased Risk of Serious Liver Injury Seen With NOACs

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Googling of Cardiac Symptoms Tracks With Hospital Admissions for Coronary Disease

Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Weighing of Female Sex in Stroke Risk Scores Needs Rethink in A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content